Market Research Blog

Phytogenics improve the aroma and taste of feed, which in turn increase feed intake and accelerate digestion activity in livestock. Adoption of feed phytogenics has led toward improvement in livestock development and growth. Growing demand for animal products including eggs, dairy, & meat has pressurized the livestock farmers in improving productivity of livestock. However, rise in cost of feed has added to the dilemma of productivity optimization for farmers, while demanding for minimal expenses.

Rising Commercialisation in Livestock Sector propelling Demand for Feed Phytogenics

On account of the aforementioned factors, feed phytogenics have emerged as the best available option for minimizing feed expanses of dairy farm, by making improvements in feed conversion ratio and feed digestion. The livestock sector has witnessed a tremendous rise in commercialisation since the recent past, which in turn has propelled the demand for feed phytogenic among livestock producers worldwide.

Future Market Insights (FMI), in its recently published research report, has projected the global feed phytogenic market to ride on an impressive CAGR over the forecast period, 2017 to 2026. Nearly US$ 2,500 Mn revenues are estimated to be accounted by global sales of feed phytogenic by 2026-end.

Increasing Emphasis on Feeding Livestock with Feed Additives Based on Natural Sources to Fuel Demand for Feed Phytogenics

Consumers across the globe are becoming more concerned about the food quality, owing to increasing occurrences of Salmonella and E. coli in meat and dairy products. Consumers are therefore shifting their preference toward processed meat and products, as these are manufactured under hygienic conditions. This has further led toward an increasing emphasis on feeding livestock animals with feed additives based on natural sources, thereby driving demand for feed phytogenics. Government organizations and manufacturers are making significant investments in research & development activities associated with feed phytogenics. However high cost of feed phytogenics, owing to stringent regulations imposed on product approvals, might act as a restraining factor for adoption of feed phytogenic in the near future.

Consumer health concerns regarding natural and healthy diet, particularly in meat & dairy products, has witnessed a rise in European countries. In addition, the European Union (EU) has banned adoption of in-feed antibiotics for livestock production. These factors have led to substantial demand for natural source-based meat & dairy products in the region, thereby resulting into increased demand for feed phytogenics. Europe is anticipated to remain the most lucrative market for feed phytogenics, followed by Europe. Asia-Pacific excluding Japan will also remain a lucrative region for growth of the feed phytogenic market.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-5622

Key Research Findings from FMI’s Report on Global Feed Phytogenic Market

• Dominance of essential oils among products will remain unchallenged in the market. Sales of oleoresins will reflect the fastest expansion through 2026.
• Feed phytogenic sales for poultry will ride on the highest CAGR through 2026, based on livestock. Between swine and aquatic animals, the former will account for larger revenue share of the market, while feed phytogenic sales for the latter will register a relatively higher CAGR during the forecast period.
• Palatability enhancers will remain the largest function of feed phytogenics, followed by performance enhancers. These two functions of feed phytogenics will account for over 80% revenue share of the market during 2017 to 2026.

Get a Customized Scope to Match Your Need Ask an Expert@

https://www.futuremarketinsights.com/ask-question/rep-gb-5622

Leading Players are boosting their Operational & Technological Capabilities for Staying at Market’s Forefront

Through strategies such as acquisitions, expansions, research agreements, and new product developments, companies producing feed phytogenics have been focusing on expansion of their presence across the globe. Leading players in the global feed phytogenic market are now boosting their operational and technological capabilities for staying at the forefront of the market. Potential opportunities exist for manufacturers of feed phytogenics across developing regions. Market players identified by FMI’s report include Igusol, Nutricare Life Sciences Ltd., Nor-Feed Sud, Natural Remedies Pvt. Ltd., Phytosynthese, A&A Pharmachem Inc., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Dostofarm GmbH, Biomin Holding GmbH, Kemin Industries, Inc., E. I. Du Pont De Nemours and Company, and Cargill Incorporated.

Market Taxonomy

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Essential Oils
• Herbs & Spices
• Oleoresins
• Others Product Type

Livestock

• Poultry
• Ruminants
• Swine
• Aquatic Animals
• Other Livestock Animals

Function

• Performance Enhancers
• Palatability Enhancers
• Other Functions

Read Related Reports:

https://synkretic.mn.co/posts/22561455

https://wecanchat.mn.co/posts/22561460

https://bipolarjungle.mn.co/posts/22561469

https://draft.blogger.com/u/2/blog/posts/7932723825500874767

https://pastelink.net/396wna7u

https://latestresearchreports.tumblr.com/post/681506365564502016/egg-white-powder-market-global-industry-analysis

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs

The market for pulse flours is primarily driven by the flour’s health benefits. Pulse flours provide protein, fibre, and agricultural micronutrients while also reducing fat, which is an unusual characteristic in a diet. To improve the health benefits of gluten-free products, a tiny amount of pulse flour can be added.

Pulse flour is attracting consumers all around the world because of its distinctiveness, which is driving the industry. The US, India, and Canada are emerging markets for pulse flours, making it a viable market.

Pulse flours are commonly made from peas and chickpeas. Pulse Flour is ideal for making a wide range of snacks that cannot be made with wheat flour or any other flour. As a result of its diverse benefits, the Pulse Flour market is likely to develop over the forecast period.

Because of capital expenditures for in-house cooking, product uniformity, electricity costs, and stricter waste and environmental restrictions, tortilla and chip makers are switching to Pulse Flour instead of alternative flours.

Pulse Flour, on the other hand, comes with some limitations. Pulse flour quality is solely reliant on the type of pulse utilized and the pulse production technique used, both of which can degrade flour quality. Climate, rainfall, water sources and quality of water, as well as pesticides and manure utilized, all affect the quality of the completed product or flour.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6123

Key Highlights

• Chickpea pulse flour segment is expected to expand at 11.6% CAGR over the forecast period.
• Chickpea segment is estimated to account for 33.2% revenue share of the product type segment by 2021 end and is expected to gain 247 BPS in its market share by 2031 over 2021.
• Chickpea segment is expected to create absolute $ opportunity of US$ 6,440.5 Mn between 2017 and 2026
• The largest share is contributed by APEJ region in chickpea market. This is expected to represent 50.5% of the market in 2021, to reach 54.4%, representing a CAGR across forecast period of 12.6%.

“Rising population and per capita food consumption to fuel global demand. Also, increasing application in preparing nutrition and protein blends creating opportunities for market players “said a lead analyst at FMI.

Who is winning?

Some of the leading companies offering pulse flours are Anchor Ingredients Co. Llc., Archer Daniels Midland Company, Batory Foods, Inc., Bean Growers Australia Limited, Best Cooking Pulses Inc., Blue Ribbon Grain & Pulses Pty Ltd, CanMar Grain Products, Diefenbaker Spice & Pulse, Ehl Ingredients Limited, Great Western Grain Company Ltd, Ingredion Incorporated, Parakh Agro Industries Limited, SunOpta, Inc., The Scoular Company, and others.

Get a Customized Scope to Match Your Need Ask an Expert@

https://www.futuremarketinsights.com/ask-question/rep-gb-6123

Get Valuable Insights into Pulse flours market 

Future Market Insights, in its new offering, provides an unbiased analysis of the pulse flours market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031.

The study divulges compelling insights on the pulse flours market based on product type (chickpea, lentils, pea, beans, and other product types), application (bakery and confectionery, extruded products, beverages, animal feed, dairy products, and other applications), and distribution channel (food chain services, modern trade, convenience store, departmental store, online store, and other distribution channels) across seven major regions.

Read Related Reports:

https://hackmd.io/X_K4vNDSQaG0K1hUarpmhw

https://acatpg.mn.co/posts/22561383

https://globalsocials.mn.co/posts/22561387

https://drujrake.mn.co/posts/22561391

https://marketresearchtrends.hashnode.dev/egg-white-powder-market-growth-future-prospects-and-competitive-analysis-2022-to-2032

https://cipmo-system.mn.co/posts/22561422

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs

In the last few years consumers have become more selective about their food choices. Rising awareness among consumers has spurred the demand for prefer healthier, better quality and ecological food products. Fish is a widely available nutrient rich food source with high protein, minerals and vitamin content. Therefore, fish consumption has considerably increased over the years. Projected to rise at a CAGR of ~6 between 2019 and 2026, Future Market Insights foresees stable growth for the market.

Key Takeaways from the Fish Powder Market Study

• According to the report, several manufacturers are expanding their global footprint through acquisition of major regional players. This is also intended to expand their product offerings and increase the number manufacturing facilities. Currently key players are focusing on opening innovative development centres to boost manufacturing capabilities in the targeted country and improve their global presence.
• Since there is limited production of fish powder, leading manufacturers are now focusing on improving their distribution base in the global market in order to make sure the product is readily available to its target customers.
• Among various end-use segments, the usage of fish powder in animal feed is most common. Owing to the increasing health awareness and growing preference for processed food/diet with low fat, sugar, salt and high protein content, the demand for fish powder is considerably rising in the food & beverages segment.
• Technologies that are expected to gain prominence in the upcoming years are influenced   by various macroeconomic factors that may also change the course of growth. Also, emergence of new technologies is likely in the near future. These technologies can replace the existing ones or render their traditional counterparts completely obsolete. The financial situation and the company’s manufacturing these products will select the course of the growth of these technologies

To remain ‘ahead’ of your competitors, request for @

https://www.futuremarketinsights.com/reports/sample/rep-gb-7820

“Key players are anticipated to focus on improving their horizontal integration to reduce the uncertainties associated with the supply of consistent quantity and quality of raw materials. Furthermore, upcoming entrants in the fish powder market are specifically expected to focus on incorporation of more advanced processing technologies mainly which are environment friendly as well as economical to grow as a leader in the market.” says an FMI analyst.

The consumption of fish has markedly increased on account of promotion campaigns undertaken and increasing consumers concerns regarding healthy and sustainable life. In addition to this, factors such as population growth, increase in per capita disposable income, healthy food consumption trend, and urbanization also have a positive impact on the market.

The demand for pet foods offering high protein, low carbohydrates and grain free diets is persistently increasing. In addition to this, there is a rise in the number of pet food products with “limited ingredients” and “novel ingredients” with an expanding “No” list of wheat, corn, soy, potato, beet pulp, beef and other byproducts.  As a result these factors, fish meal has been quite popular among pet owners since the last few years.

Get a Customized Scope to Match Your Need Ask an Expert@

https://www.futuremarketinsights.com/ask-question/rep-gb-7820

Who is winning?

Some of the key players operating in the fish powder market are Omega Protein Corporation, Bio-marine Ingredients Ireland Ltd., Scanbio Marine Group AS, Bio-Oregon Protein, Inc., TripleNine Group A/S, Sopropeche S.A., Alaska Protein Recovery LLC., Titan Biotech Limited, A Costantino & C. S.P.A., Oceana Group Limited S.A., Empresas Copec S.A., Ff Skagen A/S., Biomega AS., Sardina D.O.O., Pesquera Diamante S.A., Austevoll Seafood ASA., Colpex International S.A.C., Symrise AG, and others.

Several leading market players are acquiring smaller businesses to expand their footprint and product portfolio. Besides this, acquisition often allows them to gain competitive advantage.

• In 2015, Oceana Group Limited S.A. acquired the fishing business of Foodcrop Limited. This acquisition deal was carried out through an investment of around US$ 34.5 Mn. This acquisition is entitled to pelagic fishing rights, which is expected to benefit the group enabling expansion of its fishmeal production capacity.
• In October 2017, FF Skagen AS acquired Skagerak Pelagic from Skagerak Group. Through this acquisition it entered into the market of pelagic fish for human consumption. Skagerak Pelagic is Denmark’s largest producer of herring for human consumption, producing around 30,000 metric tons of finished herring products.

Get Valuable Insights into Fish Powder Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global Fish Powder market, presenting historical demand data (2014-2018) and forecast statistics for the period from 2019-2029. The study divulges compelling insights on the Fish Powder market based on the product type (fish meal powder and fish protein powder), end user (food & beverages, cosmetics & personal care, sports nutrition & dietary supplement, pharmaceuticals, fertilizers, and animal feed (animal feed segment is further categorized into aqua feed, poultry, and swine)), and distribution channel (B2B and B2C (B2C is segmented into Store based retailing and online retailing) across seven major regions.

Read Related Reports:

https://hackmd.io/X_K4vNDSQaG0K1hUarpmhw

https://acatpg.mn.co/posts/22561383

https://globalsocials.mn.co/posts/22561387

https://drujrake.mn.co/posts/22561391

https://marketresearchtrends.hashnode.dev/egg-white-powder-market-growth-future-prospects-and-competitive-analysis-2022-to-2032

https://cipmo-system.mn.co/posts/22561422

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs

The global respiratory pathogen testing kits market was valued at US$2.49 Bn in 2019 up by 5% over 2018. As per study conducted by Future Market Insights (FMI), the market will witness a substantial CAGR of 6.5% between 2020 and 2030.

The report states that the prevalence of microbial infections in the form of common cold, pneumonia, tuberculosis, influenza, bronchitis, and the latest – Covid-19 is driving the manufacturers towards increased production of respiratory pathogen testing kits. The global conglomerates are entering into partnership with local players to suffice the increasing demand for these kits.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10542

This report encloses in-depth insights into the respiratory pathogen testing kits market. A few of them are:

• The market is estimated to reach US$ 2.65 Bn by the end of 2020.
• Numerous companies are opting for strategic expansion in Asia Pacific due to the ever-increasing incidences of pathogen-centric diseases (more so due to population density in Asia Pacific). Some of them are also tying up with local players to address the increasing demand and provide affordable kits.
• Extensive research being funded by governments/government agencies is contributing to the growth of market and this trend is expected to continue in the forecast period as well.

Outbreak of Covid-19 To Spur the Demand for Respiratory Pathogen Testing Kits

The existing medical conditions impelling the respiratory pathogen testing kits market include bronchitis, pneumonia, TB, influenza, common cold, and tonsillitis. The outbreak of Covid-19 has bolstered the market as the number of cases are rising every single day at an alarming rate.

To employ corrective measures within the stipulated timeframe; it’s imperative to have respiratory pathogen testing kits in place. Flagship companies along with government bodies are coming together to keep pace with regards to these kits availability.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-10542 
On the other hand, certain high-risk professions like coal mines are subject to safety guidelines by their respective governments. These workers, over the period of time, encounter COPD (Chronic Obstructive Pulmonary Disease) as they unknowingly inhale silica dust (abreast with bacteria).

The governments mandate regular health check-ups of these workers. As such, these workplaces do make use of respiratory pathogen testing kits for reporting the HQ (health quotient) of the workers. This consistent demand is likely to hold the flag high for respiratory pathogen testing kits market.

Who Is In Win-Win Situation?

The key respiratory pathogen testing market players covered by FMI include Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Mobidiag, iGenetic Diagnostics, Hoffmann-La Roche Ltd., etc.

They are focusing on devising innovative products with competitive pricing, thus expecting to account for maximum market share. The other measures include collaborating with regional market players in the Asia Pacific region in order to expand their clientele and grab respiratory pathogen testing kits market share in emerging economies.

Heavily investing in research to expand product portfolio and market presence globally, especially to cater to the needs of end users, consolidating their positions through mergers, acquisitions, and new product launches is also on the anvil.

Know More About Inclusions In FMI’s Report

Future Market Insights, through its latest offering, brings wide-spread analysis at global, regional, and country levels. Historical demand data (2015-2019) and forecast statistics (2020-2030) are presented. The global respiratory pathogen testing kits market covers every aspect of the respiratory pathogen testing kits market and tables a complete market intelligence approach to the reader.

The study provides compeling insights on respiratory pathogen testing kits market on basis of product type (RT-PCR Kits, DFA Kits, ELISA Kits and Others), by infections/symptoms (Enterovirus Infection, Human Corona Virus Infection, Influenza Virus Infection, Respiratory Syncytial Virus Infection, Rhinovirus Infection, Pneumonia and others), by Technology (Nucleic acid amplification, Immunoassay and others) and End User (Diagnostic Centers, Hospitals and specialty clinics) across seven major regions.

Contact Us
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

 

Projected to reach global market revenues of over US$ 4 Bn by the end of 2030, home healthcare continues to receive a strong impetus from a shifting preference for a value-based healthcare delivery model.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11594

Expensive hospital stays, coupled with evolving patient expectations and advancing technologies, are putting immense pressure on healthcare systems to reimagine the way healthcare is delivered over the years. Home-based primary care and hospital-at-home care will continue to make significant strides in the near future, according to a new Future Market Insights (FMI) study on the global home healthcare market.

However, adoption of home healthcare products and solutions has been on a slight decline since Q1 2022 due to evolving priorities of industry amid the global outbreak of COVID-19. Nationwide lockdowns, shutdown of production units, and considerable alternations in supply chains are currently challenging the progress of home healthcare market. The market is however set for a rapid rebound post the containment of coronavirus.

As per the Bureau of Labor Statistics, increasing workforce pertaining to healthcare services translates to rising need for personal healthcare and home health aides will outperform the capital performance of the healthcare sector, with over 4 million jobs in the homecare sector alone.

Key Takeaways of Home Healthcare Market Study

• Prevalence of chronic diseases, especially among the geriatric population, is opening a broad array of opportunities for home healthcare companies.
• Infusion pumps would remain preferred among various home healthcare products such as pressure relief devices; ostomy drainage bags to follow closely.
• Stoma care would be the prominent application area in home healthcare market; key players to invest in IV medication.
• North America and Europe continue to offer opportunities of growth and profitability, owing to strong presence of leading players and rising adoption of home healthcare services.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11594 

Leading Manufacturers Capitalize on Product Portfolio Expansion and Distributional Partnerships

A majority of companies are focused on development of innovative home healthcare. Several prominent players are investing in expansion of their product portfolio thorough acquisitions in order to extend their geographical reach. For instance, the famous BD and C.R. Bard merger gave rise to a new global healthcare leader. With an aim to expand operations in the UK, Medline had announced opening of its new warehouse in the UK, in 2018.

Some of the prominent players in home healthcare industry that are profiled in the FMI report, include Coloplast A/S, Baxter International Inc, B. Braun Melsungen AG, Hollister Incorporated, ConvaTec Group Plc, Medtronic plc., and Becton Dickinson and Co.

Know More About Report Inclusions

The FMI report brings to fore a comprehensive research on the market growth forecast at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Home Healthcare market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on Home Healthcare market on basis of product type (infusion systems, pressure relief devices, hydrocolloid dressings, hydrofibre dressings, hydrogel dressings, semi-permeable film dressings, superabsorbent dressings, wound contact layers, gauze sponges, gauzes, sponges, ostomy drainage bags), application (total parenteral nutrition (TPN), IV medication, pressure ulcer, stoma care), across seven major regions.

Contact Us
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

Expanding patient pool suffering from cancer, cardiovascular diseases, and dental and orthopedic disorders is primarily driving the need for dual and multi-energy CT techniques. Continuous focus on the introduction of technologically-advanced devices is expected to propel the growth of the dual and multi-energy computed tomography market over the forecast period of 2022 to 2029.

Amidst the coronavirus pandemic, healthcare systems across the world are overwhelmed; they are running short of supplies such as viral testing kits. This translates to increasing measures of isolation and medical screening.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11301 

Dual and multi-energy CT is crucial in the early detection of COVID-19, including its nature and extent of damage. As the number of confirmed cases of COVID-19 accelerate, especially in developed regions, dual and multi-energy CT would be critical in the large-scale screening of suspected individuals.

Key Takeaways of Dual and Multi-energy CT Market Study

• The dual-source CT segment under product type contributed maximum value share in the global dual and multi-energy CT market in 2018, owing to the increasing adoption of dual-source CT and easy availability of the device.
• CT angiography is expected to be the leading clinical application, resulting in a notable share of the segment in the dual and multi-energy computed tomography market.
• The hospitals segment under end user holds above 50% of value share in the dual and multi-energy CT market.
• North America holds around 35% revenue share, and is expected to be the most lucrative region in the global dual and multi-energy computed tomography market during the forecast period.
• Increasing government funding to boost the growth of the medical industry in Asia is expected to drive the growth of the dual and multi-energy CT market in the region.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11301 

Aging Population and Need for Medical Imaging

Increasing aging population with longer life expectancy, especially in developed regions, is anticipated to boost the medical and healthcare industry.

According to the data of the National Institutes of Health (NIH), patients aging 65 years and above undergo diagnostic imaging at rate twice or thrice that of the younger population. Women are also subject to use higher rates of imaging as compared to men. This results in a rise in the number of diagnostic procedures and more effective treatment methods.

Factors such as evolving patient expectations regarding quality of care is also driving the demand for advanced imaging technology, thus boosting the overall imaging market.

Contact Us
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

Global medical protective equipment market will experience a major upturn in 2022 and onwards, amid the global COVID-19 pandemic, reaching a projected valuation of over US$ 41 Bn through 2030.

The growing pandemic of community infections owing to emergence of new pathogens is expected to increase the demand of medical protective equipments in the global market. This rising number of community and hospital acquired infections will drive market growth in the near future, says a new Future Market Insights (FMI) report.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11296 

Key manufacturers operating in the market offer a wide range of products such as medical masks, gloves, protective clothing, gowns and other products. Owing to non-availability of treatment for new pathogen infections and significant lag phase between the emergence of new pathogen and development of effective treatment, there has been an increasing demand for medical protective equipment, creating an absolute opportunity for growth of the medical protective market.

Covid-19 Pandemic Crisis Fosters Demand

Sudden virus pandemic situation has created huge gap between supply and demand of medical protective equipments. Recently in December 2019, Covid-19 pandemic has been emerged across the global geographies. This highly-transmissible respiratory disease has significantly rise the unmet demand of medical masks, gloves and other protective equipments.

For instance, according to WHO study, WHO has advised personal protective equipment industry and governments to increase manufacturing by 40% to meet rising global demand of personal protective equipment (PPE) amid global Covid-19 outbreak.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11296 

Key Takeaways of Medical Protective Equipment Market Study

• Medical gloves segment is expected to contribute more than 40% of revenue share in the medical protective equipment market.
• Owing to use of gloves in prevention of primary infections and to perform surgical procedures by healthcare workers, medical gloves segment is the most dominated product type.
• Disposable medical protective equipment will gain more than 75% of market share in the medical protective equipment market throughout the forecast period.
• Hospitals and NGO’s/ government organization segments are expected to collectively gain more than 60% of market share in the medical protective equipment market during 2022-2030.
• Europe is the highest revenue generating market by region due to aging population and high rate of new pathogenic infections. North America is expected to offer lucrative opportunities owing to higher incidence of new infections and increasing volume of innovative surgical procedures.

Manufacturing Collaborations Preferred to Tackle Massive Demand Growth

Leading manufacturers in the medical protective equipment market are extensively focusing on expansion of their manufacturing capabilities in the disruptive demand. Government is actively encouraging local manufacturers to prioritise an emergency demand of medical protective equipments in the public hospitals and other healthcare set-ups.

For instance, in March 2020, the 3M Company, the U. S. based global leader in medical protective equipments has collaborated with giant automobile manufacturer Ford to transform auto manufacturing facility into respirators manufacturing plant.

Contact Us
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

In recent years, non-opioid pain patches have gained huge attention of leading industry players due to the addictive risk and safety concerns of alternative opioid pain analgesics. In addition, governments and regulatory bodies are encouraging non-addictive alternative therapies for acute and chronic pain treatment.

Leading industry players in the non-opioid pain patches market are tapping this opportunity by allocating significant investments towards the R&D of novel transdermal non-opioid pain technologies. Continuous innovation in these novel drugs is expected to drive the non-opioid pain patches market in the decade ahead.

Key manufacturers operating in the market are offering a wide range of products such as lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others. Owing to the non-addictiveness of non-opioid pain therapeutics, there has been increasing demand for non-opioid pain patches, creating opportunity for the growth of the non-opioid pain patches market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11286

FMI – a well-established name in the market research domain – forecasts that, the non-opioid pain patches market will experience a major upturn post 2025, crossing the US$ 4 Bn mark by 2029.

That being said, the market is likely to witness decline in the near term due to the novel coronavirus (COVID-19) pandemic. The impact of the pandemic has been prominent in China, where the virus originated, and Europe – Spain, Italy, and France. Consequently, governments in these regions have imposed total lockdowns, leading to logistic nightmares, and gradual exhausting of existing non-opioid pain patches.

“Rising demand for safe and alternative chronic pain therapeutics, and supportive government policies, are anticipated to shape the future of long-term acting transdermal non-opioid analgesic patches.”

Key Takeaways of Non-opioids Pain Patches Market Study

• In terms of product type, the lidocaine patches segment is expected to capture over 65% of revenue share in the non-opioid pain patches market.
• Owing to superior topical effectiveness with minimal side-effects and prolonged transdermal drug release, lidocaine patches are the most preferred product type.
• In terms of distribution channel, hospital pharmacies and retail pharmacies & drug stores are expected to collectively hold over 70% of total value in the non-opioid pain patches market during the forecast period.
• North America is the highest revenue generating market by region, due to high R&D projects and conducive regulatory environment for non-opioid pain therapeutics. Europe is expected to offer lucrative opportunities, owing to the large aging population and increasing per capital healthcare expenditure.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11286

Strategic Collaborations – Key Differentiating Strategy Followed by Leading Manufacturers

Leading manufacturers in the non-opioid pain patches market are focusing on external development collaboration to innovate novel therapeutics, in a bid to sustain market competition. For instance, in April 2021, Seattle-based Kineta Chronic Pain collaborated with Genentech to develop a non-opioid drug for the treatment of chronic pain. The underdevelopment drug is α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists, a novel target for the treatment of chronic neuropathic pain.

Want more insights?

A new study by Future Market Insights on the non-opioid pain patches market opines on the indications of non-opioids pain patches from 2014–2021, and presents demand projections for 2022–2029, on the basis of product type (lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others) and distribution channel (hospital pharmacies, retail pharmacies & drug stores, and online pharmacies), across seven prominent regions.

Contact Us
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs